Skip to main content

Table 1 Correlation between ERCC6L protein expression in HCC and the clinical characteristics of HCC patients (n = 90)

From: ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

Clinical characteristics

n

ERCC6L expression

X2

P

Low

High

Age, years

  <  50

27

9

16

0.207

0.810

  ≥ 50

63

26

37

  

Gender

 Female

16

2

14

6.580

0.012

 Male

74

35

39

  

Liver cirrhosis

 No

73

32

41

0.475

0.584

 Yes

17

5

12

  

Tumor size, cm

  <  5

31

15

16

1.034

0.370

  ≥ 5

59

22

37

  

Tumor number

 Single

83

32

51

2.882

0.119

 Multiple

7

5

2

  

Tumor encapsulation

 Complete

65

33

32

9.016

0.004

 None

25

4

21

  

Pathological stage

 I-II

64

31

33

4.912

0.027

 III-IV

26

6

20